156 related articles for article (PubMed ID: 30945681)
1. Clinical relationships between the rs2212020 and rs189897 polymorphisms of the
Liu J; Liu T; Liang L; He J; Zhang M; Ge Y; Liao S; Zhou Y; Zhang K
J Genet; 2019 Mar; 98():. PubMed ID: 30945681
[TBL] [Abstract][Full Text] [Related]
2. [Association of ITGA9 gene rs189897 and rs2212020 genotypes and its haplotype with cerebral infarction].
Li XM; Li J; Zeng F; Yi H
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(7):1142-5. PubMed ID: 21764681
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor (VEGF) polymorphism and increased risk of epithelial ovarian cancer.
Rinck-Junior JA; Oliveira C; Lourenço GJ; Sagarra RA; Derchain SF; Segalla JG; Lima CS
J Cancer Res Clin Oncol; 2015 Jan; 141(1):69-73. PubMed ID: 25092217
[TBL] [Abstract][Full Text] [Related]
4. ERCC1, XRCC1, and GSTP1 Polymorphisms and Treatment Outcomes of Advanced Epithelial Ovarian Cancer Patients Treated with Platinum-based Chemotherapy.
Liblab S; Vusuratana A; Areepium N
Asian Pac J Cancer Prev; 2020 Jul; 21(7):1925-1929. PubMed ID: 32711417
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study.
Bagnoli M; Canevari S; Califano D; Losito S; Maio MD; Raspagliesi F; Carcangiu ML; Toffoli G; Cecchin E; Sorio R; Canzonieri V; Russo D; Scognamiglio G; Chiappetta G; Baldassarre G; Lorusso D; Scambia G; Zannoni GF; Savarese A; Carosi M; Scollo P; Breda E; Murgia V; Perrone F; Pignata S; De Cecco L; Mezzanzanica D;
Lancet Oncol; 2016 Aug; 17(8):1137-1146. PubMed ID: 27402147
[TBL] [Abstract][Full Text] [Related]
6. The androgen receptor cytosine-adenine-guanine repeat length contributes to the development of epithelial ovarian cancer.
Meng X; Lu P; Chu Z; Fan Q
Oncotarget; 2016 Jan; 7(2):2105-12. PubMed ID: 26556855
[TBL] [Abstract][Full Text] [Related]
7. Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genes.
Fridley BL; Jenkins GD; Tsai YY; Song H; Bolton KL; Fenstermacher D; Tyrer J; Ramus SJ; Cunningham JM; Vierkant RA; Chen Z; Chen YA; Iversen E; Menon U; Gentry-Maharaj A; Schildkraut J; Sutphen R; Gayther SA; Hartmann LC; Pharoah PD; Sellers TA; Goode EL
Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):529-36. PubMed ID: 22302016
[TBL] [Abstract][Full Text] [Related]
8. The CYP1A1 Ile462Val polymorphism and platinum resistance of epithelial ovarian neoplasms.
Heubner M; Wimberger P; Riemann K; Kasimir-Bauer S; Otterbach F; Kimmig R; Siffert W
Oncol Res; 2010; 18(7):343-7. PubMed ID: 20377136
[TBL] [Abstract][Full Text] [Related]
9. Common variants at 19p13 are associated with susceptibility to ovarian cancer.
Bolton KL; Tyrer J; Song H; Ramus SJ; Notaridou M; Jones C; Sher T; Gentry-Maharaj A; Wozniak E; Tsai YY; Weidhaas J; Paik D; Van Den Berg DJ; Stram DO; Pearce CL; Wu AH; Brewster W; Anton-Culver H; Ziogas A; Narod SA; Levine DA; Kaye SB; Brown R; Paul J; Flanagan J; Sieh W; McGuire V; Whittemore AS; Campbell I; Gore ME; Lissowska J; Yang HP; Medrek K; Gronwald J; Lubinski J; Jakubowska A; Le ND; Cook LS; Kelemen LE; Brooks-Wilson A; Massuger LF; Kiemeney LA; Aben KK; van Altena AM; Houlston R; Tomlinson I; Palmieri RT; Moorman PG; Schildkraut J; Iversen ES; Phelan C; Vierkant RA; Cunningham JM; Goode EL; Fridley BL; Kruger-Kjaer S; Blaeker J; Hogdall E; Hogdall C; Gross J; Karlan BY; Ness RB; Edwards RP; Odunsi K; Moyisch KB; Baker JA; Modugno F; Heikkinenen T; Butzow R; Nevanlinna H; Leminen A; Bogdanova N; Antonenkova N; Doerk T; Hillemanns P; Dürst M; Runnebaum I; Thompson PJ; Carney ME; Goodman MT; Lurie G; Wang-Gohrke S; Hein R; Chang-Claude J; Rossing MA; Cushing-Haugen KL; Doherty J; Chen C; Rafnar T; Besenbacher S; Sulem P; Stefansson K; Birrer MJ; Terry KL; Hernandez D; Cramer DW; Vergote I; Amant F; Lambrechts D; Despierre E; Fasching PA; Beckmann MW; Thiel FC; Ekici AB; Chen X; ; ; ; Johnatty SE; Webb PM; Beesley J; Chanock S; Garcia-Closas M; Sellers T; Easton DF; Berchuck A; Chenevix-Trench G; Pharoah PD; Gayther SA
Nat Genet; 2010 Oct; 42(10):880-4. PubMed ID: 20852633
[TBL] [Abstract][Full Text] [Related]
10. Kallikrein-related peptidase 3 (KLK3/PSA) single nucleotide polymorphisms and ovarian cancer survival.
O'Mara TA; Nagle CM; Batra J; Kedda MA; Clements JA; Spurdle AB
Twin Res Hum Genet; 2011 Aug; 14(4):323-7. PubMed ID: 21787114
[TBL] [Abstract][Full Text] [Related]
11. [Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy].
Qi BL; Li Y; Wang N; Zhou RM; Hu P; Kang S
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):847-52. PubMed ID: 24444563
[TBL] [Abstract][Full Text] [Related]
12. Elevated growth differentiation factor 15 expression predicts poor prognosis in epithelial ovarian cancer patients.
Zhang Y; Hua W; Niu LC; Li SM; Wang YM; Shang L; Zhang C; Li WN; Wang R; Chen BL; Xin XY; Zhang YQ; Wang J
Tumour Biol; 2016 Jul; 37(7):9423-31. PubMed ID: 26781874
[TBL] [Abstract][Full Text] [Related]
13. The AA genotype of a L1C G842A polymorphism is associated with an increased risk for ovarian cancer.
Heubner M; Wimberger P; Kasimir-Bauer S; Otterbach F; Kimmig R; Siffert W
Anticancer Res; 2009 Aug; 29(8):3449-52. PubMed ID: 19661372
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of cadherin 17 and down-regulation of homeodomain protein CDX2 correlate with tumor progression and unfavorable prognosis in epithelial ovarian cancer.
Huang LP; Yu YH; Sheng C; Wang SH
Int J Gynecol Cancer; 2012 Sep; 22(7):1170-6. PubMed ID: 22810971
[TBL] [Abstract][Full Text] [Related]
15. CD105/Ki67 coexpression correlates with tumor progression and poor prognosis in epithelial ovarian cancer.
Liu P; Sun YL; Du J; Hou XS; Meng H
Int J Gynecol Cancer; 2012 May; 22(4):586-92. PubMed ID: 22266931
[TBL] [Abstract][Full Text] [Related]
16. Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study.
Beltrame L; Di Marino M; Fruscio R; Calura E; Chapman B; Clivio L; Sina F; Mele C; Iatropoulos P; Grassi T; Fotia V; Romualdi C; Martini P; Noris M; Paracchini L; Craparotta I; Petrillo M; Milani R; Perego P; Ravaggi A; Zambelli A; Ronchetti E; D'Incalci M; Marchini S
Ann Oncol; 2015 Jul; 26(7):1363-71. PubMed ID: 25846551
[TBL] [Abstract][Full Text] [Related]
17. Epithelial Ovarian Cancer Metastatic to the Central Nervous System and a Family History Concerning for Hereditary Breast and Ovarian Cancer--A Potential Relationship.
Jernigan AM; Mahdi H; Rose PG
Int J Gynecol Cancer; 2015 Sep; 25(7):1232-8. PubMed ID: 26067864
[TBL] [Abstract][Full Text] [Related]
18. Association of tRNA methyltransferase NSUN2/IGF-II molecular signature with ovarian cancer survival.
Yang JC; Risch E; Zhang M; Huang C; Huang H; Lu L
Future Oncol; 2017 Sep; 13(22):1981-1990. PubMed ID: 28829218
[TBL] [Abstract][Full Text] [Related]
19. Identification of the coexisting HER2 gene amplification and novel mutations in the HER2 protein-overexpressed mucinous epithelial ovarian cancer.
Lin WL; Kuo WH; Chen FL; Lee MY; Ruan A; Tyan YS; Hsu JD; Chiang H; Han CP
Ann Surg Oncol; 2011 Aug; 18(8):2388-94. PubMed ID: 21347793
[TBL] [Abstract][Full Text] [Related]
20. Second-line Intraperitoneal Platinum-based Therapy Leads to an Increase in Second-line Progression-free Survival for Epithelial Ovarian Cancer.
Boisen MM; Lesnock JL; Richard SD; Beriwal S; Kelley JL; Zorn KK; Edwards RP
Int J Gynecol Cancer; 2016 May; 26(4):626-31. PubMed ID: 27051048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
